Search results
From history to controversy: 5 things to know about Memorial Day
Military Times via Yahoo News· 2 hours agoThe day is supposed to be about mourning the nation’s fallen service members, but it’s come to...
‘Atlas’ has finally landed on Netflix — and the reviews are just as shocking as the movie’s AI
Tom's Guide via Yahoo News· 3 days agoMagazine said: “Atlas seems like a story that should have been experienced with a gamepad in hand.”...
Man killed after shooting in Pleasant Grove
KDFW via Yahoo News· 13 hours agoGeneric police lights (FOX 9) DALLAS - One man is dead after a late-night shooting in the Pleasant Grove area. It happened around 10:30 p.m. Saturday in...
Plano teenager arrested in connection to other teen boy's shooting death
KDFW via Yahoo News· 13 hours agoGeneric image of police lights. PLANO, Texas - Plano police have arrested a teenager in connection...
Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla
Zacks· 6 days agoFree Report) entered into a settlement agreement with Cipla, which was looking to market a generic...
Florida Lottery "Generic Scratch" Watch to Win contest
CBS News· 6 hours agoTo participate in the contest, watch WFOR or WBFS from 7:00pm-7:30pm (for the duration of the...
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
Reuters via Yahoo News· 4 hours agoIndia is a hub of bulk generic drug manufacturing and drugmakers including Dr Reddy's, Cipla, Sun...
Divi's Labs Surpasses Q4 Expectations, Yet Valuations Remain a Concern
Investing.com· 9 hours agoDivi's Labs Surpasses Q4 Expectations, Yet Valuations Remain a Concern
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
WJET - WFXP Erie· 1 hour ago"We have confidence in viltolarsen and continue our commitment to the Duchenne community," said the NS Pharma President. Viltolarsen was approved by the United States (US) Food...
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Zacks via Yahoo Finance· 2 hours agoHealthcare Solutions segment are expected to grow 11-13% for fiscal 2024. Operating income is...